Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07419321Recruiting

Social Isolation and Aging in Schizophrenia

Role: collaborator

NCT06101810Not ApplicableRecruiting

The Efficacy of Treatments to Improve Self-esteem

Role: lead

NCT05942495Not ApplicableCompleted

SFGT for Persistent Anxiety and Depression

Role: lead

NCT06749041Not Yet Recruiting

Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic Drug Monitoring

Role: lead

NCT06617663Not ApplicableRecruiting

Online Therapy Youth, Equivalent to Treatment As Usual?

Role: lead

NCT05726812Completed

Plan My Life Together; a Group Training for Adolescents With ADHD

Role: lead

NCT05711342Not ApplicableUnknown

The Added Value of an Internet-based Intervention for Treatment of Forensic Psychiatric Outpatients

Role: collaborator

All 7 trials loaded